SEC Form 4 · accession 0001214659-18-002135
HUMANIGEN, INC · HGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy E Morris
Director
Period of report
Mar 9, 2018
Accepted (ET)
Mar 13, 2018 · 9:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293310
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $0.665 | Mar 9, 2018 | A | 715,877 | A | Jun 30, 2018 | Mar 8, 2028 | Common Stock | 715,877 | 715,877 | D |
| Stock Option (Right to Buy)F2 | $0.665 | Mar 9, 2018 | A | 88,235 | A | Mar 9, 2018 | Mar 8, 2028 | Common Stock | 88,235 | 88,235 | D |
Explanation of responses
- F1The option vests in 12 ratable quarterly installments commencing June 30, 2018.
- F2These stock options were granted in lieu of 50% of the cash compensation payable to Mr. Morris in respect of his services as a director during 2017.